Home > Financial Ratios > AARTI PHARMALABS

AARTI PHARMALABS
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for AARTI PHARMALABS
Please provide your vote to see the results

AARTI PHARMALABS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 21.3713.5264.41--

What is the latest Core EBITDA Growth ratio of AARTI PHARMALABS ?

The latest Core EBITDA Growth ratio of AARTI PHARMALABS is 21.37 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202521.37
Mar202413.52
Mar202364.41
Mar2022-
Mar2021-

How is Core EBITDA Growth of AARTI PHARMALABS Trending?

Years Core EBITDA Growth % Change
Mar2025 21.37
58.06
Mar2024 13.52
-79.01
Mar2023 64.41
0
Mar2022 0
0
Mar2021 0 -

Other Financial Ratios of AARTI PHARMALABS


Compare Core EBITDA Growth ratio of peers of AARTI PHARMALABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AARTI PHARMALABS ₹6,409.3 Cr 2.1% -3.5% -4.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹420,531.0 Cr 1.3% 8.9% 6% Stock Analytics
DIVIS LABORATORIES ₹169,989.0 Cr 2.4% 6% 12.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹147,936.0 Cr -0.6% 9.4% 44.1% Stock Analytics
CIPLA ₹109,200.0 Cr 1.9% 2% -8.7% Stock Analytics
DR REDDYS LABORATORIES ₹108,057.0 Cr -0.4% 9.5% 10.5% Stock Analytics


AARTI PHARMALABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AARTI PHARMALABS

2.1%

-3.5%

-4.5%

SENSEX

-3.7%

-2.5%

6.5%


You may also like the below Video Courses